|
1
|
Janssen-Heijnen ML, van Erning FN, De
Ruysscher DK, Coebergh JW and Groen HJ: Variation in causes of
death in patients with non-small cell lung cancer according to
stage and time since diagnosis. Ann Oncol. 26:902–907.
2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Giatromanolaki A, Sivridis E, Arelaki S
and Koukourakis MI: Expression of enzymes related to glucose
metabolism in non-small cell lung cancer and prognosis. Exp Lung
Res. 43:167–174. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Patra KC, Wang Q, Bhaskar PT, Miller L,
Wang Z, Wheaton W, Chandel N, Laakso M, Muller WJ, Allen EL, et al:
Hexokinase 2 is required for tumor initiation and maintenance and
its systemic deletion is therapeutic in mouse models of cancer.
Cancer Cell. 24:213–228. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Patra KC and Hay N: The pentose phosphate
pathway and cancer. Trends Biochem Sci. 39:347–354. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Riganti C, Gazzano E, Polimeni M, Aldieri
E and Ghigo D: The pentose phosphate pathway: An antioxidant
defense and a crossroad in tumor cell fate. Free Radic Biol Med.
53:421–436. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Pavlova NN and Thompson CB: The emerging
hallmarks of cancer metabolism. Cell Metab. 23:27–47.
2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Li F, Han X, Li F, Wang R, Wang H, Gao Y,
Wang X, Fang Z, Zhang W, Yao S, et al: LKB1 Inactivation elicits a
redox imbalance to modulate non-small cell lung cancer plasticity
and therapeutic response. Cancer Cell. 27:698–711. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zeng C, Wu Q, Wang J, Yao B, Ma L, Yang Z,
Li J and Liu B: NOX4 supports glycolysis and promotes glutamine
metabolism in non-small cell lung cancer cells. Free Radic Biol
Med. 101:236–248. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhou L, Li M, Yu X, Gao F and Li W:
Repression of hexokinases II-mediated glycolysis contributes to
piperlongumine-induced tumor suppression in non-small cell lung
cancer cells. Int J Biol Sci. 15:826–837. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kitamura K, Ohata M, Narata M, Iida M,
Ohmori K, Irako M, Nakamura S, Natori H and Sezai Y: Surgical
treatment of bilateral spontaneous pneumothorax. Nihon Kyobu Geka
Gakkai Zasshi. 37:117–122. 1989.PubMed/NCBI(In Japanese).
|
|
12
|
Zhang JG, Guo JF, Liu DL, Liu Q and Wang
JJ: MicroRNA-101 exerts tumor-suppressive functions in non-small
cell lung cancer through directly targeting enhancer of zeste
homolog 2. J Thorac Oncol. 6:671–678. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang RT, Xu M, Xu CX, Song ZG and Jin H:
Decreased expression of miR216a contributes to non-small-cell lung
cancer progression. Clin Cancer Res. 20:4705–4716. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261.
2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Martinez I, Gardiner AS, Board KF, Monzon
FA, Edwards RP and Khan SA: Human papillomavirus type 16 reduces
the expression of microRNA-218 in cervical carcinoma cells.
Oncogene. 27:2575–2582. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Davidson MR, Larsen JE, Yang IA, Hayward
NK, Clarke BE, Duhig EE, Passmore LH, Bowman RV and Fong KM:
MicroRNA-218 is deleted and downregulated in lung squamous cell
carcinoma. PLoS One. 5(e12560)2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tatarano S, Chiyomaru T, Kawakami K,
Enokida H, Yoshino H, Hidaka H, Yamasaki T, Kawahara K, Nishiyama
K, Seki N and Nakagawa M: miR-218 on the genomic loss region of
chromosome 4p15.31 functions as a tumor suppressor in bladder
cancer. Int J Oncol. 39:13–21. 2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zeng XJ, Wu YH, Luo M, Cong PG and Yu H:
Inhibition of pulmonary carcinoma proliferation or metastasis of
miR-218 via down-regulating CDCP1 expression. Eur Rev Med Pharmacol
Sci. 21:1502–1508. 2017.PubMed/NCBI
|
|
19
|
Chiu KL, Kuo TT, Kuok QY, Lin YS, Hua CH,
Lin CY, Su PY, Lai LC and Sher YP: ADAM9 enhances CDCP1 protein
expression by suppressing miR-218 for lung tumor metastasis. Sci
Rep. 5(16426)2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zarogoulidis P, Petanidis S, Kioseoglou E,
Domvri K, Anestakis D and Zarogoulidis K: miR-205 and miR-218
expression is associated with carboplatin chemoresistance and
regulation of apoptosis via Mcl-1 and Survivin in lung cancer
cells. Cell Signal. 27:1576–1588. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Li P, Yang X, Cheng Y, Zhang X, Yang C,
Deng X, Li P, Tao J, Yang H, Wei J, et al: MicroRNA-218 increases
the sensitivity of bladder cancer to cisplatin by targeting Glut1.
Cell Physiol Biochem. 41:921–832. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yuan X, Tian W, Hua Y, Hu L, Yang J, Xie
J, Hu J and Wang F: Rhein enhances the cytotoxicity of effector
lymphocytes in colon cancer under hypoxic conditions. Exp Ther Med.
16:5350–5358. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Jiang J, Geng G, Yu X, Liu H, Gao J, An H,
Cai C, Li N, Shen D, Wu X, et al: Repurposing the anti-malarial
drug dihydroartemisinin suppresses metastasis of non-small-cell
lung cancer via inhibiting NF-κB/GLUT1 axis. Oncotarget.
7:87271–87283. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yang Y, Ding L, Hu Q, Xia J, Sun J, Wang
X, Xiong H, Gurbani D, Li L, Liu Y and Liu A: MicroRNA-218
functions as a tumor suppressor in lung cancer by targeting
IL-6/STAT3 and negatively correlates with poor prognosis. Mol
Cancer. 16(141)2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Abbaszadeh Z, Çeşmeli S and Biray Avcı Ç:
Crucial players in glycolysis: Cancer progress. Gene.
726(144158)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yan Y, Yan F and Huang Q: miR-200c
inhibited the proliferation of oral squamous cell carcinoma cells
by targeting Akt pathway and its downstream Glut1. Arch Oral Biol.
96:52–57. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Santasusagna S, Moreno I, Navarro A, Muñoz
C, Martinez F, Hernández R, Castellano JJ and Monzo M: miR-328
mediates a metabolic shift in colon cancer cells by targeting
SLC2A1/GLUT1. Clin Transl Oncol. 20:1161–1167. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhou Y, Zheng X, Lu J, Chen W, Li X and
Zhao L: Ginsenoside 20(S)-Rg3 inhibits the warburg effect via
modulating DNMT3A/ miR-532-3p/HK2 pathway in ovarian cancer cells.
Cell Physiol Biochem. 45:2548–2559. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yang Y, Ishak Gabra MB, Hanse EA, Lowman
XH, Tran TQ, Li H, Milman N, Liu J, Reid MA, Locasale JW, et al:
miR-135 suppresses glycolysis and promotes pancreatic cancer cell
adaptation to metabolic stress by targeting phosphofructokinase-1.
Nat Commun. 10(809)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
He C and Yang J, Ding J, Li S, Wu H, Xiong
Y, Zhou F, Jiang Y, Teng L and Yang J: Downregulation of
glucose-6-phosphate dehydrogenase by microRNA-1 inhibits the growth
of pituitary tumor cells. Oncol Rep. 40:3533–3542. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yang J, Kou J, Lim JE, Lalonde R and
Fukuchi KI: Intracranial delivery of interleukin-17A via
adeno-associated virus fails to induce physical and learning
disabilities and neuroinflammation in mice but improves glucose
metabolism through AKT signaling pathway. Brain Behav Immun.
53:84–95. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Song DH, Getty-Kaushik L, Tseng E, Simon
J, Corkey BE and Wolfe MM: Glucose-dependent insulinotropic
polypeptide enhances adipocyte development and glucose uptake in
part through Akt activation. Gastroenterology. 133:1796–1805.
2007.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Belgardt BF, Mauer J, Wunderlich FT, Ernst
MB, Pal M, Spohn G, Brönneke HS, Brodesser S, Hampel B, Schauss AC
and Brüning JC: Hypothalamic and pituitary c-Jun N-terminal kinase
1 signaling coordinately regulates glucose metabolism. Proc Natl
Acad Sci USA. 107:6028–6033. 2010.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Xu G, Wang Z, Li Y, Li Z, Tang H, Zhao J,
Xiang X, Ding L, Ma L, Yuan F, et al: Ghrelin contributes to
derangements of glucose metabolism induced by rapamycin in mice.
Diabetologia. 55:1813–1823. 2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zhang W, Thompson BJ, Hietakangas V and
Cohen SM: MAPK/ERK signaling regulates insulin sensitivity to
control glucose metabolism in Drosophila. PLoS Genet.
7(e1002429)2011.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Li Q, Li Y, Liang L1, Li J, Luo D, Liu Q,
Cai S and Li X: Klotho negatively regulated aerobic glycolysis in
colorectal cancer via ERK/HIF1α axis. Cell Commun Signal.
16(26)2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Mauro C, Leow SC, Anso E, Rocha S,
Thotakura AK, Tornatore L, Moretti M, De Smaele E, Beg AA,
Tergaonkar V, et al: NF-κB controls energy homeostasis and
metabolic adaptation by upregulating mitochondrial respiration. Nat
Cell Biol. 13:1272–1279. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
40
|
Kawauchi K, Araki K, Tobiume K and Tanaka
N: p53 regulates glucose metabolism through an IKK-NF-kappaB
pathway and inhibits cell transformation. Nat Cell Biol.
10:611–618. 2008.PubMed/NCBI View
Article : Google Scholar
|
|
41
|
Gilmore TD: Introduction to NF-kappaB:
players, pathways, perspectives. Oncogene. 25:6680–6684.
2006.PubMed/NCBI View Article : Google Scholar
|
